<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The nuclear <z:chebi fb="0" ids="25354">mineralocorticoid</z:chebi> receptor (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>), a high-affinity receptor for <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi>, is highly expressed in the hippocampus where it underpins cognitive, behavioural and neuroendocrine regulation </plain></SENT>
<SENT sid="1" pm="."><plain>Increased neuronal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> expression occurs early in the response to cellular injury in vivo and in vitro and is associated with enhanced neuronal survival </plain></SENT>
<SENT sid="2" pm="."><plain>To determine whether increased neuronal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> might be causal in protecting against ischaemic damage in vivo we generated a forebrain-specific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-overexpressing transgenic mouse (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-Tg) under the control of the CamKII alpha promoter, and subjected mice to transient cerebral global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> induced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 20 min </plain></SENT>
<SENT sid="3" pm="."><plain>We also separately assessed the effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> overexpression on hypothalamic-pituitary-adrenal (<z:chebi fb="5" ids="53393">HPA</z:chebi>) axis activity and cognitive and affective functions in noninjured animals </plain></SENT>
<SENT sid="4" pm="."><plain>Our results showed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-Tg mice had significantly reduced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> following transient cerebral global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> compared to <z:mp ids='MP_0002169'>wild-type</z:mp> littermates </plain></SENT>
<SENT sid="5" pm="."><plain>This effect was not associated with alterations in basal or poststress <z:chebi fb="5" ids="53393">HPA</z:chebi> axis function or in arterial blood pressure </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>-Tg mice also demonstrated improved spatial memory retention, reduced <z:hpo ids='HP_0000739'>anxiety</z:hpo> and altered behavioural response to novelty </plain></SENT>
<SENT sid="7" pm="."><plain>The induction of neuronal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> appears to offer a protective response which has potential therapeutic implications in <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> and cognitive and <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">affective disorders</z:e> </plain></SENT>
</text></document>